Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1999 2
2000 1
2001 2
2004 4
2006 1
2007 3
2008 4
2009 4
2010 3
2011 6
2012 8
2013 6
2014 6
2015 7
2016 5
2017 17
2018 12
2019 11
2020 16
2021 28
2022 13
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 31740571

142 results
Results by year
Filters applied: . Clear all
Page 1
Management of Membranous Nephropathy after MENTOR.
Trivin-Avillach C, Beck LH Jr. Trivin-Avillach C, et al. Clin J Am Soc Nephrol. 2020 Mar 6;15(3):415-417. doi: 10.2215/CJN.10240819. Epub 2019 Nov 18. Clin J Am Soc Nephrol. 2020. PMID: 31740571 Free PMC article. No abstract available.
A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).
Fervenza FC, Canetta PA, Barbour SJ, Lafayette RA, Rovin BH, Aslam N, Hladunewich MA, Irazabal MV, Sethi S, Gipson DS, Reich HN, Brenchley P, Kretzler M, Radhakrishnan J, Hebert LA, Gipson PE, Thomas LF, McCarthy ET, Appel GB, Jefferson JA, Eirin A, Lieske JC, Hogan MC, Greene EL, Dillon JJ, Leung N, Sedor JR, Rizk DV, Blumenthal SS, Lasic LB, Juncos LA, Green DF, Simon J, Sussman AN, Philibert D, Cattran DC; Mentor Consortium group. Fervenza FC, et al. Nephron. 2015;130(3):159-68. doi: 10.1159/000430849. Epub 2015 Jun 12. Nephron. 2015. PMID: 26087670 Clinical Trial.
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.
Fervenza FC, Appel GB, Barbour SJ, Rovin BH, Lafayette RA, Aslam N, Jefferson JA, Gipson PE, Rizk DV, Sedor JR, Simon JF, McCarthy ET, Brenchley P, Sethi S, Avila-Casado C, Beanlands H, Lieske JC, Philibert D, Li T, Thomas LF, Green DF, Juncos LA, Beara-Lasic L, Blumenthal SS, Sussman AN, Erickson SB, Hladunewich M, Canetta PA, Hebert LA, Leung N, Radhakrishnan J, Reich HN, Parikh SV, Gipson DS, Lee DK, da Costa BR, Jüni P, Cattran DC; MENTOR Investigators. Fervenza FC, et al. N Engl J Med. 2019 Jul 4;381(1):36-46. doi: 10.1056/NEJMoa1814427. N Engl J Med. 2019. PMID: 31269364 Clinical Trial.
Rituximab Immunomonitoring Predicts Remission in Membranous Nephropathy.
Teisseyre M, Cremoni M, Boyer-Suavet S, Crepin T, Benzaken S, Zorzi K, Esnault V, Brglez V, Seitz-Polski B. Teisseyre M, et al. Front Immunol. 2021 Oct 13;12:738788. doi: 10.3389/fimmu.2021.738788. eCollection 2021. Front Immunol. 2021. PMID: 34721403 Free PMC article.
Primary Membranous Nephropathy.
Couser WG. Couser WG. Clin J Am Soc Nephrol. 2017 Jun 7;12(6):983-997. doi: 10.2215/CJN.11761116. Epub 2017 May 26. Clin J Am Soc Nephrol. 2017. PMID: 28550082 Free PMC article. Review.
142 results